Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 3Phase 2 3Phase 1/2 3Phase 1 3Phase NA 1

Status

Unknown 3Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Multiple Myeloma 25Breast Neoplasms 21Colorectal Neoplasms 17Neoplasms 16Prostatic Neoplasms 15Lymphoma, B-Cell 15Stomach Neoplasms 13Carcinoma, Hepatocellular 12Recurrence 11Pancreatic Neoplasms 11Lung Neoplasms 11Leukemia, Myeloid, Acute 11Carcinoma, Non-Small-Cell Lung 11Burkitt Lymphoma 11Solid Tumor 10Uterine Cervical Neoplasms 9Lymphoma, Non-Hodgkin 9Glioblastoma 9Leukemia 8Ovarian Neoplasms 7Glioma 7Sarcoma 6Polycystic Ovary Syndrome 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma 5Hematologic Neoplasms 5Head and Neck Neoplasms 5Neuroendocrine Tumors 4Lymphoma, T-Cell, Peripheral 4

Interventions

fludarabine 1Cyclophosphamide 1(225)Ac-PSMA-617 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Unknown × Metastatic Castration-resistant Prostate Cancer × Clear all
NCT05558956 2023-07-27

Total Body PET-CT Imaging of Prostate Cancer Using Illuccix

BAMF Health

Phase EARLY_PHASE1 Unknown
100 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT03692663 2022-08-01

Study of Anti-PSMA CAR NK Cell (TABP EIC) in Metastatic Castration-Resistant Prostate Cancer

Allife Medical Science and Technology Co., Ltd.

Phase EARLY_PHASE1 Unknown
9 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT04225910 2020-01-13

Clinical Trial of Ac225-PSMA Radioligand Therapy of Metastatic Castration-resistant Prostate Cancer

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Phase EARLY_PHASE1 Unknown
20 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡